Hypertrophic pachymeningitis as a rare cause of headaches: a clinical case
https://doi.org/10.25789/YMJ.2024.87.24
Abstract
The article presents a description of the clinical case of a 62-year-old woman who had been suffering from headaches for 5 months. MRI of the brain revealed pachymeningeal enhancement, especially in frontal-parietal regions, and tentorium cerebellum. Based on the clinical picture and neuroimaging data, the patient was diagnosed with idiopathic hypertrophic pachymeningitis. Corticosteroid therapy resulted in regression of pain and reduction of MRI changes. The article also discusses the difficulties of differential diagnostics of hypertrophic pachymeningitis with other diseases, which can be imitated by clinical picture and changes on MRI images.
About the Authors
A. A. Tappakhov
M.K. Ammosov North-Eastern Federal University (Yakutsk) Medical Institute of M.K. Ammosov NEFU
Russian Federation
Russian Federation
Tappakhov Alexey Alekseevich – Candidate of Medical Sciences, Associate Professor, senior researcher YSC CMP
A. N. Ylakhova
M.E. Nikolaev Republican Hospital No. 1 National Center of Medicine (Yakutsk)
Russian Federation
Russian Federation
Ylakhova Anastasia Nikolaevna – neurologist
N. V. Luginov
M.E. Nikolaev Republican Hospital No. 1 National Center of Medicine (Yakutsk)
Russian Federation
Russian Federation
Luginov Nikolay Vasilievich – Candidate of Medical Sciences, head of the Department of Radiology
L. T. Okoneshnikova
M.E. Nikolaev Republican Hospital No. 1 National Center of Medicine (Yakutsk)
Russian Federation
Russian Federation
Okoneshnikova Lyudmila Timofeevna – head of the Department
T. Ya. Nikolayeva
M.K. Ammosov North-Eastern Federal University (Yakutsk) Medical Institute of M.K. Ammosov NEFU
Russian Federation
Russian Federation
Nikolaeva Tatiana Yakovlevna – Doctor of Medical Sciences, head of the department
A. V. Bulatov
M.E. Nikolaev Republican Hospital No. 1 National Center of Medicine (Yakutsk)
Russian Federation
Russian Federation
Bulatov Alkviad Valentinovich – Candidate of Medical Sciences, Director
References
1. Intracranial hypotension / Ramazanov G.R., Shevchenko E.V., Izmailova A.M. [et al.] // Bulletin of the Smolensk State Medical Academy. 2021. Vol. 20, No. 1. P. 159-167. doi :10.37903/vsgma.2021.1.24
2. Hypertrophic basal pachymeningitis extended to the orbit, combined with Tolosa-Hunt syndrome: description of a clinical case / Ivanov V.V., Shestakov A.A., Gorozhanin A.V. [et al.] // A.L. Polenov Russian Neurosurgical Journal. 2022. Vol. 14, No. 4. P. 111-116. doi: 10.56618/20712693_2022_14_4_111
3. Diagnosis and treatment of migraine: recommendations of Russian experts / Osipova V. V., Filatova E. G., Artemenko A. R. [et al.] //s. S. Korsakov Journal of Neurology and Psychiatry. 2018. Vol. 48, No. 5. P. 621-635. doi:10.1007/s11055-018-0608-2
4. Mendelevich E. G., Fattakhova Ch. S., Bogdanov E. I. Hypertrophic pachymeningitis: modern criteria for diagnosis and differentiation (clinical observation and literature review) // Neurology, neuropsychiatry, psychosomatics. 2015. T. 7 (2). P. 42-46. doi: 10.14412/2074-2711-2015-2-42-46
5. A clinical approach to hypertrophic pachymeningitis. / Abrantes F. F., de Moraes M. P. M., Rezende Filho F. M. [et al.] // Arquivos de neuro-psiquiatria. 2020. T. 78, Vol. 12. P. 797-804. doi: 10.1590/0004-282X20200073
6. A rare case report on hypertrophic pachymeningitis: Serum IgG4-related disease / Rayamajhi S., Shrestha R., Sunuwar N. [et al.] // Radiology Case Reports. 2022. T. 17, Vol. 11. P. 4371-4375. doi: 10.1016/j.radcr.2022.08.044
7. Anti-GFAP Antibody-Associated Hypertrophic Pachymeningitis / Tan C., Zhong M., Yao Z. [et al.] // Neuropediatrics. 2022. T. 53, Vol. 2. P. 143-145. doi: 10.1055/s-0042-1742718
8. Charleston L., Cooper W. An Update on Idiopathic Hypertrophic Cranial Pachymeningitis for the Headache Practitioner // Current Pain and Headache Reports. 2020. T. 24, Vol. 10. doi: 10.1007/s11916-020-00893-5
9. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease / De Virgilio A., de Vincentiis M., Inghilleri M. [et al.] // Immunologic Research. 2017. T. 65, Vol. 1. P. 386-394. doi:10.1007/s12026-016-8863-1
10. IgG4-Related Disease Presenting as Hypertrophic Pachymeningitis /sapkota B., Rampure R., Gokden M., Kanuru S. // Cureus. 2022. T. 14, Vol. 2. doi: 10.7759/cureus.21850
11. IgG4-Related hypertrophic pachymeningitis clinical features, diagnostic criteria, and treatment / Lu L. X., Della-Torre E., Stone J. H., Clark S. W. // JAMA Neurology. 2014. T. 71, Vol. 6. P. 785-793. doi:10.1001/jamaneurol.2014.243
12. Jagiasi, K., Barvalia P. Is Hypertrophic Pachymeningitis Really Idiopathic? // Neurology India. 2022. T. 70, Vol. 6. P. 2422-2426. doi: 10.4103/0028-3886.364052
13. Sergio P., Alejandro R., Cristian F. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report. // Reumatologia clinica. 2023. T. 19, Vol. 6. P. 338-344. doi: 10.1016/j.reumae.2023.05.001
14. Spontaneous intracranial hypotension: diagnostic and therapeutic workup / Luetzen N., Dovi-Akue P., Fung C. [et al.] // Neuroradiology. 2021. T. 63, Vol. 11. P. 1765-1772. doi:10.1007/s00234-021-02766-z
Review
For citations:
Tappakhov A.A., Ylakhova A.N., Luginov N.V., Okoneshnikova L.T., Nikolayeva T.Ya., Bulatov A.V. Hypertrophic pachymeningitis as a rare cause of headaches: a clinical case. Yakut Medical Journal. 2024;(3):117-121. https://doi.org/10.25789/YMJ.2024.87.24
Views:
29
Email this article 